Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Townsend Richard Nolan
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Townsend Richard Nolan
Lexeo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Eventide Asset Management, LLC(6.65%),Finny Kuruvilla, M.D. Ph. D.(6.65%), etc.
Lexeo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(10.3%),Janus Henderson Biotech Innovation Master Fund Ltd(5.1%)
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Townsend Richard Nolan
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Van Hauwermeiren Timothy
Lexeo Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Van Hauwermeiren Timothy
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director COOPERSTONE BRENDA
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Altschuler Steven
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DIAZ REINALDO M
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Agger Mette Kirstine
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CHOLMONDELEY PAULA H
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Otero Jose Manuel
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Townsend Richard Nolan
Lexeo Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Otero Jose Manuel
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Townsend Richard Nolan
Lexeo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(7.8%),Citadel Advisors Holdings LP(7.8%), etc.
Lexeo Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals
Lexeo Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lundbeckfond Invest A/S(6.9%),Lene Skole(6.9%)
Lexeo Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Janus Henderson Group plc(8.7%)
No Data
No Data